Canada Markets open in 8 hrs 54 mins

Kindred Biosciences, Inc. (KIN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.0500-0.1400 (-3.34%)
At close: 4:00PM EDT
Currency in USD

Valuation Measures

Market Cap (intraday) 5159.44M
Enterprise Value 3120.67M
Trailing P/E N/A
Forward P/E 1-4.09
PEG Ratio (5 yr expected) 1-0.09
Price/Sales (ttm)40.11
Price/Book (mrq)1.84
Enterprise Value/Revenue 330.36
Enterprise Value/EBITDA 6-1.97

Trading Information

Stock Price History

Beta (5Y Monthly) 0.90
52-Week Change 3-40.99%
S&P500 52-Week Change 3N/A
52 Week High 311.9300
52 Week Low 33.1050
50-Day Moving Average 33.9854
200-Day Moving Average 35.6353

Share Statistics

Avg Vol (3 month) 3446.25k
Avg Vol (10 day) 3351.02k
Shares Outstanding 539.37M
Float 30.32M
% Held by Insiders 15.96%
% Held by Institutions 167.66%
Shares Short (Jul. 14, 2020) 4638.63k
Short Ratio (Jul. 14, 2020) 41.41
Short % of Float (Jul. 14, 2020) 42.12%
Short % of Shares Outstanding (Jul. 14, 2020) 41.63%
Shares Short (prior month Jun. 14, 2020) 4479.36k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Jun. 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,608.00%

Management Effectiveness

Return on Assets (ttm)-34.29%
Return on Equity (ttm)-30.46%

Income Statement

Revenue (ttm)3.98M
Revenue Per Share (ttm)0.10
Quarterly Revenue Growth (yoy)-29.90%
Gross Profit (ttm)3.67M
EBITDA -61.26M
Net Income Avi to Common (ttm)-29.74M
Diluted EPS (ttm)-0.7650
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)67.12M
Total Cash Per Share (mrq)1.71
Total Debt (mrq)22.83M
Total Debt/Equity (mrq)26.30
Current Ratio (mrq)10.47
Book Value Per Share (mrq)2.21

Cash Flow Statement

Operating Cash Flow (ttm)-17.45M
Levered Free Cash Flow (ttm)-32.69M